1,851
Participants
Start Date
April 24, 2018
Primary Completion Date
April 30, 2024
Study Completion Date
July 15, 2024
Cerebrolysin
Dosage, frequency, duration and mode of administration of Cerebrolysin follow the local hospital practice in accordance with the terms of the local marketing authorization and is not amended or influenced by the study. Prescribed Cerebrolysin will be used as solution for injection/concentrate for solution for infusion.
LK Wiener Neustadt, Wiener Neustadt
UK St. Pölten, Sankt Pölten
Landesklinikum Amstetten, Amstetten
UK Tulln, Tulln
Kepler Universitätsklinikum, Linz
CDK Salzburg, Universitätsklinik für Neurologie, Salzburg
Universitätsklinik Innsbruck, Innsbruck
Krankenhaus der Barmherzigen Brüder Eisenstadt, Eisenstadt
Lead Sponsor
IDV Data analysis and study planning Dr. Rahlfs
UNKNOWN
Ever Neuro Pharma GmbH
INDUSTRY